Global Biologics Market 2019 – Investment Strategy, Outlook and Key Development till 2023

Biologics Market – Overview

Biologics are biologic drugs that are derived or semi-synthesized from natural sources such as humans, animals and micro-organisms with the use of biotechnology. As per the report that has been published by Market Research Future (MRFR), the global biologics market is anticipated to expand at a noteworthy CAGR of 8.6% during the forecast period 2017-2023.

Market Drivers and Key Restraints

The global market for biologics is majorly driven by the availability of wide range of biologics such as vaccines, allergenics, blood, blood components, somatic cells, tissues, gene therapies, living cells used in cell therapy and recombinant therapeutic protein. The increasing number of individuals with chronic and acute diseases, such as cancer, diabetes, anemia and others, that involves biologics in their treatment is inducing demand for biologics or biologic drugs in the global market.

Get Free Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1339

The growing approval of patient-centric and personalized medicines and increasing resistance towards conventional drugs are impacting positively on the expansion of the global biologics market. The increasing inclination towards the adoption of medicines that are derived from natural sources owing to the high rate of side-effects caused by the conventional chemically synthesized drugs is creating traction for biologics in the global market, resulting in the expansion of the global biologics market.

The high success rate in terms of approval of biologic drugs has created a broad pathway of opportunities for the manufacturers, which in turn is fueling the growth of the global biologics market. The increased research and development expenditure by the pharmaceutical companies has led to the introduction of new and efficient biologic drugs in the global market, leading to the expansion of the global biologics market. However, the high capital investment for research and development of biologics, high cost of biologics and development of biosimilars are likely to act as a restraint on the growth of the global biologics market.

Global Biologic Market is Expected to Grow at a CAGR of 8.6% during Forecasted Period 2017-2023.

Market Opportunities

Introduction of Personalized Medicines Supports Market Growth

With drastic developments in gene and cell therapies, antibody drug conjugates and immunotherapies, the expected growth of biologics in the future is touted to be excellent. Trade pundits predict that biopharmaceuticals are poised to maintain their growth trend backed by innovative technologies and therapies. Personalized medicine and regenerative therapy are two areas that are developing at a speedy rate. Furthermore, personalized medicines that are based on immunotherapies, antibody drug conjugates and gene therapies are exhibited to be introduced in following years, which will offer lot of promise for regenerative medicine and focused disease remission. Key Players for Global Biologics Market

Key Players

Sanofi (France), Pfizer Inc. (U.S.), Amgen (U.S.), F. Hoffman-La Roche AG (Switzerland), AbbVie Inc. (U.S.), Bayer AG (Germany), AstraZeneca (U.K.), GlaxoSmithKline Plc (U.K.), Novartis AG (Switzerland), Eli Lilly and Company (U.S.), are among some of the leading companies in the global biologics market.

Five players out of these are at the top with over 70% share of the total market, which are Roche, AbbVie, Amgen, GSK and Pfizer.

Recent Developments

April 2019

WuXi Biologics and NBE-Therapeutics (NBE) have entered into a partnership, and are in the process of developing and manufacturing NBE's first ADC lead product known as NBE-002 (anti-ROR1). The product refers to an immune-stimulatory ADC (iADC) treatment that protects against ROR1 cancer target.

Global Biologics Industry Competitive Analysis

The increasing research and development expenditure for new product launch by the manufacturers in the global market is strengthening the competition in the global biologics market. The players in the market are focusing on the expansion of their business through strategic mergers and acquisitions in order to sustain the highly competitive environment of the global biologics market.

In July 2018, the European Union and Japan have extended their current mutual recognition agreement. This extension has led to the inclusion of certain biologic medicines, sterile medicines and APIs which suggests that these medicines will no longer be inspected once they are delivered to the others’ territory.

Segments for Global Biologics Market

The global biologics market has been segmented on the basis of type, application and source. Based on type, the biologics market is segmented into vaccines, blood products, proteins, gene therapy, monoclonal antibodies and others. Significant development and high adoption of vaccines are leading to the expansion of vaccine segment in the global biologics market.

Based on application, the biologics market is segmented into anemia, cancer, diabetes and others. Among these, the cancer segment is anticipated to dominate the global biologics market during the forecast period. Based on source, the biologics market is segmented into human, animals and micro-organisms.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/biologics-market-1339

Regional Analysis for Global Biologics Market

The global biologics market is geographically segmented into four major regions such as America, Europe, Asia Pacific and the Middle East and Africa. Among these, the Americas is anticipated to dominate the global biologics market owing to the high prevalence of diseases such as cancer and diabetes. The Europe region accounts for the second largest share of the global biologics market owing to the increasing healthcare expenditure and rise in government support for research and development of biologics in this region. The increasing geriatric population and demand for biologic products are driving the expansion of the biologics market in the Asia Pacific region. However, the low penetration of advanced medications and poor healthcare facilities in the underdeveloped regions of the Middle East and Africa are leading to the steady growth of the biologics market in this region.

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

Do You Have Specific Requirement? Ask To Our Experts@ https://www.marketresearchfuture.com/enquiry/1339

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

We enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Re